JSB Market Research: In Vitro Diagnostic (IVD) Market Technique & Applications – Forecast To 2017
In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] Forecast To 2017
On 13rd June 2014
The report focuses on "In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] Forecast To 2017"
Factors such as the continuous technological advancements in the field of diagnostics and an increase in healthcare awareness have made In Vitro Diagnostic testing an indispensable tool in current medical practices.
In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017. The advancements in molecular techniques, increasing awareness and acceptance of personalized medicines, rise in the occurrence of chronic diseases, and the need for the diagnosis of such diseases at early stages are the key factors driving the growth of the molecular diagnostics market. On the other hand, the development of a large variety of reagents and analytical techniques, and inexpensive automated testing known as point-of-care (POC) are the factors leading to the growth in the reagents market.
Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-In-Vitro-Diagnostic-IVD-Market-Instruments-Reagents-Data-Management-Systems-63690
The oncology diagnostics market is the fastest growing segment in in vitro diagnostic applications. Major players such as Roche Diagnostics, Siemens Healthcare, and Hologic are continuously launching new in vitro diagnostics products for the detection of cancer. In addition, point-of-care
On 13rd June 2014
The report focuses on "In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] Forecast To 2017"
Factors such as the continuous technological advancements in the field of diagnostics and an increase in healthcare awareness have made In Vitro Diagnostic testing an indispensable tool in current medical practices.
In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017. The advancements in molecular techniques, increasing awareness and acceptance of personalized medicines, rise in the occurrence of chronic diseases, and the need for the diagnosis of such diseases at early stages are the key factors driving the growth of the molecular diagnostics market. On the other hand, the development of a large variety of reagents and analytical techniques, and inexpensive automated testing known as point-of-care (POC) are the factors leading to the growth in the reagents market.
Browse Full Report @ http://www.jsbmarketresearch.com/healthcare-medical/r-In-Vitro-Diagnostic-IVD-Market-Instruments-Reagents-Data-Management-Systems-63690
The oncology diagnostics market is the fastest growing segment in in vitro diagnostic applications. Major players such as Roche Diagnostics, Siemens Healthcare, and Hologic are continuously launching new in vitro diagnostics products for the detection of cancer. In addition, point-of-care